J Neonatal Perinatal Med. 2024;17(3):S447-S500. doi: 10.3233/NPM-249006. NO ABSTRACT PMID:39121143 | DOI:10.3233/NPM-249006
J Neonatal Perinatal Med. 2024;17(3):S345-S392. doi: 10.3233/NPM-249003. NO ABSTRACT PMID:39121140 | DOI:10.3233/NPM-249003
PLoS One. 2024 Aug 9;19(8):e0308523. doi: 10.1371/journal.pone.0308523. eCollection 2024. ABSTRACT BACKGROUND: Meningitis poses a significant challenge to public health in low-income nations, such as Ethiopia, …
J Public Health Manag Pract. 2024 Aug 9. doi: 10.1097/PHH.0000000000001972. Online ahead of print. ABSTRACT The present study describes the efforts of a home visiting …
JMIR Res Protoc. 2024 Aug 9;13:e55558. doi: 10.2196/55558. ABSTRACT BACKGROUND: Prepubertal transgender, nonbinary, and gender-diverse (TGD) children (ie, those asserting gender identity, expressing gender-role behavior …
Retina. 2024 Aug 12. doi: 10.1097/IAE.0000000000004222. Online ahead of print. ABSTRACT PURPOSE: Determine whether intravitreal injection of bevacizumab (IVB) exerts long-term effects on neurodevelopmental outcomes …
J Clin Oncol. 2024 Aug 9:JCO2302238. doi: 10.1200/JCO.23.02238. Online ahead of print. ABSTRACT PURPOSE: Although cure rates for childhood acute lymphoblastic leukemia (ALL) exceed 90%, …
Blood Adv. 2024 Aug 9:bloodadvances.2023012161. doi: 10.1182/bloodadvances.2023012161. Online ahead of print. ABSTRACT Acute myeloid leukemia (AML) with the t(7;12)(q36;p13) translocation occurs only in very young …
J Clin Oncol. 2024 Aug 9:JCO2400826. doi: 10.1200/JCO.24.00826. Online ahead of print. ABSTRACT PURPOSE: Revumenib, an oral, small molecule inhibitor of the menin-lysine methyltransferase 2A …
Medicine (Baltimore). 2024 Aug 9;103(32):e39244. doi: 10.1097/MD.0000000000039244. ABSTRACT The mTOR-inhibitor everolimus is a precision drug with antiepileptogenic properties approved for treatment of epilepsy in persons …
